The Technion – Israel Institute of Technology, alongside the Alfred Mann Institute (AMIT) have founded a company aimed to commercialize stem cell technology developed over the past decade by Professor Joseph Itskovitz-Eldor of the Rappaport institute. The new company, named Accellta, will market technologies and methods which will assist commercial companies and research labs in cultivating stem cells quickly, efficiently and aconomically.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Israel Foodtech Firms Meet UK Retailers, Investors In London
April 17, 2024
Facebook comments